We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy. Cancer Breakthroughs. Realized.
Home Carousel
FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection
FACIT congratulates Dr. Trevor Pugh, OICR’s Director of Genomics and Senior Principal Investigator, on being one of ten winners of the 2019 TD Ready Challenge.
The $1M award will support Dr. Pugh’s development work towards advancing a blood-based diagnostic for early cancer detection, in collaboration with Dr. Raymond Kim of the Princess Margaret Cancer Centre.
FACIT, Triphase Accelerator, Celgene, and OICR to present at Canadian Science Policy Conference 2019
Panel focuses on the recent $1B USD FACIT-Triphase Accelerator-Celgene partnership and its impact on Canadian healthcare commercialization
Titled “Ontario First in the innovation economy: impacts of a $1B USD public-private-partnership (PPP) on Canadian healthcare commercialization”, the panel seeks to highlight the outcomes and key lessons from this unprecedented partnership.
FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research
Ms. Donna Parr and Dr. Niclas Stiernholm recruited to broaden public/private equity expertise
Scaling FACIT’s impact requires new partners and expanded expertise in the management of investments and equity markets. To that end, FACIT has recruited two seasoned executives through its Executive-in-Residence (EIR) Program.
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
Next generation liquid biopsy platform to revolutionize companion diagnostics
Cellular Analytics is founded upon a proprietary microfluidic platform that enables molecular characterization of cancer at the level of single circulating tumour cells.
FACIT Features: Portfolio company KA Imaging secures Series A financing and new global strategic partner
Partnership couples KA Imaging’s portable multi-energy x-ray detector technology with advanced manufacturing expertise.
New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology.
FACIT’s Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies
Niche early-stage investment program seeds Ontario’s developing pipeline of oncology assets
FACIT announces investments in Xpan Inc. and innovations from OICR and the University of Toronto...
as of May 2019
-
$750M
Leveraged funding associated with FACIT support.
-
$40M
Funding & equity investments.
-
48
Projects at Ontario institutions or Startups supported by FACIT funding.
-
15
Companies in Ontario created by FACIT investments.
Our Strategic Partner
FACIT also facilitates technology transfer, partnerships, and collaborations with the
Ontario Institute for Cancer Research >
